COVID-19 Recovery Without B Cells or Antibodies in Patients Receiving Rituximab for Autoimmune Disease. | Iran J Kidney Dis;1(2): 159-160, 2021 03. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

COVID-19 Recovery Without B Cells or Antibodies in Patients Receiving Rituximab for Autoimmune Disease.

Zonozi, Reza; Huizenga, Noah; Charles, Richelle; Jeyabalan, Anushya; Niles, John L.

Affiliation

Zonozi R; Massachusetts General Hospital, Boston, MA, USA. rzonozi@yahoo.com.

Iran J Kidney Dis ; 1(2): 159-160, 2021 03.

Article in En | MEDLINE | ID: mdl-33764328

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Rituximab / COVID-19 Serological Testing / SARS-CoV-2 / COVID-19 / Immunologic Factors / Antibodies, Viral Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Iran J Kidney Dis Journal subject: NEFROLOGIA Year: 2021 Document type: Article Affiliation country: Estados Unidos

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Rituximab / COVID-19 Serological Testing / SARS-CoV-2 / COVID-19 / Immunologic Factors / Antibodies, Viral Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Iran J Kidney Dis Journal subject: NEFROLOGIA Year: 2021 Document type: Article Affiliation country: Estados Unidos